n,n-carbonyldiimidazole has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzano, F; Biasizzo, M; Brunella, V; Caldera, F; Cavalli, R; Riedo, C; Soster, M; Trotta, F; Uccello Barretta, G | 1 |
1 other study(ies) available for n,n-carbonyldiimidazole and Parkinson Disease
| Article | Year |
|---|---|
Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson's disease.
Topics: beta-Cyclodextrins; Imidazoles; Levodopa; Molecular Imprinting; Parkinson Disease; Polymers | 2016 |